SRSF2 and neoplasm: Macrophage reprogramming from M2 to M1 is pivotal in enhancing tumor immunotherapy.[36, 37] In this study, Sono@NAT10 achieves M1 macrophage polarization by reducing the acetylation level of SRSF2 protein and activating HDAC10, a mechanism rarely reported in prior research.